CEO of pharma giant Sanofi says businesses should stop ‘AI washing’
However, Paul Hudson, CEO of Sanofi, one of the world's leading biopharmaceutical companies, says executives may need to rein ...
How Sanofi helped allergy sufferers find routes with cleaner air
For its “Allegra Airways” campaign, the allergy medication brand used real-time pollen and air pollution data to find pockets ...
Business Insider16h
Sanofi treatment of acute myeloid leukemia granted orphan status
A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...
FiercePharma1d
MSF calls on Lilly, Novo and Sanofi to cut insulin pen prices to $1
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
Sanofi’s Allegra allergy map helps users find cleaner air routes
To combat this, allergy medication Allegra created Allegra Airways, a website designed to help find and map real-time routes ...
Sanofi Cancels Consumer Healthcare Business Spin-Off
Sanofi announced that it has entered into exclusive negotiations with the US private equity firm Clayton, Dubilier & Rice (CD&R) to transfer around 50% controlling stake in Opella.
Formation Bio collaborates with Sanofi and OpenAI to Introduce Muse, a first of its kind AI tool to accelerate patient recruitment in drug development
Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and improve drug development by optimizing patient recruitment for clinical ...
MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...
FierceBiotech7d
ASH: Sanofi's BTK inhibitor raises platelet levels in 23% of ITP patients in phase 3
Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should spark some buyer’s delight. | Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should ...
emjreviews.com1d
BMS, Gilead and Sanofi lead Q3 market cap growth
Among these, Bristol Myers Squibb, Gilead Sciences and Sanofi stood out with robust growth, while the two leading companies ...